BARDA partners with Evidation Health to identify COVID-19 infections more quickly in healthcare workers and first responders using self-monitoring and wearable devices
BARDA is pleased to announce a partnership with Evidation Health of San Mateo, California, to monitor healthcare workers and first responders by leveraging de-identified, patient-generated health data from existing wearable devices as an early warning algorithm to identify early symptoms of COVID-19.
This study is part of BARDA’s Rapidly Deployable Capabilities program to identify and pilot near term innovative solutions for identifying individuals who have COVID-19 infections. Individual and population-based data will be collated into computer models to improve “real-time” COVID-19 incidence prediction of both symptomatic and asymptomatic patients and enhance current disease surveillance systems to detect respiratory infections prior to the onset of symptoms.
SARS-CoV-2, the virus that causes COVID-19, is highly transmissible and is causing unprecedented social behavior changes in the country as many are being impacted by stay-at- home guidance’s from health officials. One of the biggest challenges with combating the virus is being able to detect those who are infected but either have not yet progressed to symptoms or will not show symptoms of the disease, as these individuals may be able to transmit without realizing it. In addition, the symptoms of COVID-19 appear to vary greatly in individuals and over the course of infection, and these will be correlated with confirmed COVID-19 diagnosis and hospitalization.
This project builds on Evidation’s current partnership with BARDA to monitor individuals for respiratory infections, such as influenza. This pilot study will demonstrate utility of empowering Americans with a novel means to self-monitor to improve health outcomes for COVID-19. The study will initiate with healthcare workers and first responders, who are our nation’s front-line responders, to more readily be diagnosed to prevent exposure to others. The study has the potential for large-scale deployment to allow Americans to determine risk of COVID-19 and to appropriately implement precautions against spread of COVID-19 and other such diseases.
This award is one component of BARDA’s rapidly expanding COVID-19 medical countermeasure portfolio; visit BARDA’s COVID-19 Portfolio to learn more.
About the Company:
The following information is provided by the company and does not indicate endorsement by the federal government of the company or its products.
Evidation Health is a new kind of health and measurement company that provides the world’s most innovative life sciences and health care companies the technology and expertise they need to understand how everyday behavior and health interact. The volume of behavior data generated from smartphones and connected sensors — including wearables and medical devices — has opened up new ways to analyze individuals’ behavior and health in real time, unlocking insights into what medicines and treatments work best and spotting significant changes in health earlier. The scale and utility of everyday behavior data has the potential to be one of the most transformative forces in medicine, and Evidation Health is leading the way.